15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Ocugen Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $7.00 to $11.00, a moderate spread. The average target of $9.50 sits 660% above the current $1.25. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.05 next quarter toward $-0.23 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Strong Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Ocugen Inc.
As of Jul, 4 of 4 firms rate OCGN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
OCGN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.05
Range $-0.06 – $-0.04 · 6 analysts · -24% YoY
Next period, 6 analysts expect Ocugen Inc to earn $-0.05 a share (range $-0.06 – $-0.04), versus $-0.07 a year earlier. Full-year consensus is $-0.22, growing to $-0.23 the year after.
REVENUE · NEXT QUARTER
$947.6K
Range $0 – $1.5M · 6 analysts · -46% YoY
Revenue is expected to reach $947.6K (range $0 – $1.5M), -45.9% year-over-year. Full-year consensus is $4.4M, rising to $11.0M next year.
Top analysts covering Ocugen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OCGN.
#1
Daniil Gataulin
Chardan Capital · Rank #36
Buy
$7.00+460.0% to target
Overall win rate
55%
+ Follow
#2
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #230
Buy
$10.00+700.0% to target
Overall win rate
37%
+ Follow
#3
Leland Gershell
Oppenheimer · Rank #254
Buy
$10.00+700.0% to target
Overall win rate
37%
+ Follow
#4
WI
Whitney Ijem
Canaccord Genuity
Buy
$11.00+780.0% to target
Coverage
—
+ Follow
#5
Michael Okunewitch
Maxim Group
Buy
$8.00+540.0% to target
Coverage
—
+ Follow
OCGN stock forecast FAQ
What is OCGN's average 12-month price target?+
The 4 analysts with a live target average $9.50 for Ocugen Inc over the next 12 months, ranging from a $11.00 high to a $7.00 low.
Is OCGN stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for OCGN?+
The Street-high target is $11.00 (Canaccord Genuity), and the Street-low is $7.00 (Chardan Capital). The average of all 4 active targets is $9.50.
How many Wall Street analysts cover OCGN?+
4 analysts have an active rating on Ocugen Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering OCGN?+
Among analysts who currently cover OCGN, Daniil Gataulin of Chardan Capital has the strongest overall Quantellect track record (Rank #36). Their current call is Buy with a $7.00 target.
What is Ocugen Inc's projected EPS for next quarter?+
The consensus estimate is $-0.05 per share (range $-0.06 – $-0.04) across 6 analysts. Full-year EPS is projected at $-0.22, rising to $-0.23 the following year.
How much revenue is Ocugen Inc expected to report next quarter?+
Consensus revenue is $947.6K (range $0 – $1.5M). Full-year revenue is projected at $4.4M, growing to $11.0M next year.
Have analysts been upgrading or downgrading OCGN lately?+
As of Jul, 4 of 4 firms rate OCGN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OCGN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
